Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospi

来源 :中国药理学报(英文版) | 被引量 : 0次 | 上传用户:li452546674
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Coronavirus disease 2019(COVID-19)broke out in December 2019.Due its high morbility and mortality,it is necessary to summarize the clinical characteristics of COVID-19 patients to provide more theoretical basis for future treatment.In the current study,we conducted a retrospective analysis of the clinical characteristics of COVID-19 patients and explored the risk factors for the severity of illness.A total of 101 COVID-19 patients hospitalized in Leishenshan Hospital(Wuhan,China)was classified into three sub-types:moderate(n=47),severe(n=36),and critical(n=18);their clinical data were collected from the Electronic Medical Record.We showed that among the 101 COVID-19 patients,the median age was 62 years(IQR 51-74);50(49.5%)patients were accompanied by hypertension,while 25(24.8%)and 22(21.8%)patients suffered from diabetes and heart diseases,respectively,with complications.All patients were from Wuhan who had a definite history of exposure to the epidemic area.Multivariate logistic regression analysis revealed that older age,diabetes,chronic liver disease,percentage of neutrophils(N%)>75%,CRP>4 mg/L,D-dimer>0.55 mg/L,IL-2R>710 U/mL,IL-8>62 pg/mL,and IL-10>9.1 pg/mL were independent variables associated with severe COVID-19.In conclusion,we have identified the independent risk factors for the severity of COVID-19 pneumonia,including older age,diabetes,chronic liver disease,higher levels of N%,CRP,D-dimer,IL-2R,IL-8,and IL-10,providing evidence for more accurate risk prediction.
其他文献
The tumor suppressor p53 is usually inactivated by somatic mutations in malignant neoplasms,and its reactivation represents an attractive therapeutic strategy for cancers.Here,we reported that a new quinolone compound RYL-687 significantly inhibited non-s
White matter injury is the major pathological alteration of subcortical ischemic vascular dementia(SIVD)caused by chronic cerebral hypoperfusion.It is characterized by progressive demyelination,apoptosis of oligodendrocytes and microglial activation,which
As a member of the potassium calcium-activated channel subfamily,increasing evidence suggests that KCNN4 was associated with malignancies.However,the roles and regulatory mechanisms of KCNN4 in PDAC have been little explored.In this work,we demonstrated t
Urate transporter 1(URAT1)and glucose transporter 9(GLUT9)are important targets for the development of uric acid-lowering drugs.We previously showed that the flexible linkers of URAT1 inhibitors could enhance their potency.In this study we designed and sy
Rheumatoid arthritis(RA)is a chronic systemic autoimmune disease characterized by synovitis and the destruction of small joints.Emerging evidence shows that immunoglobulin D(IgD)stimulation induces T-cell activation,which may contribute to diseases pathog
Our previous study showed that chronic treatment with tumor necrosis factor-α(TNF-α)decreased cAMP concentration in fibroblast-like synoviocytes(FLSs)of collagen-induced arthritis(CIA)rats.In this study we investigated how TNF-α impairs cAMP homeostasis,p
N-n-Butyl haloperidol iodide(F2)is a novel compound that has antiproliferative and antifibrogenic activities.In this study we investigated the therapeutic potential of F2 against liver fibrosis in mice and the underlying mechanisms.Two widely used mouse m
Mifepristone(Mif),an effective synthetic steroidal antiprogesterone drug,is widely used for medical abortion and pregnancy prevention.Due to its anti-glucocorticoid effect,high-dose Mif is also used to treat Cushing\'s syndrome.Mif was reported to activ
Oxidative stress-related cartilage degeneration,synovitis,and joint pain play vital roles in the progress of osteoarthritis(OA).Anti-oxidative stress agents not only prevent structural damage progression but also relieve OA-related pain.In this study,we i
EIDD-2801 is an orally bioavailable prodrug,which will be applied for emergency use autho-rization from the U.S.Food and Drug Administration for the treatment of COVID-19.To investigate the optimal parameters,EIDD-2801 was optimized via a four-step synthe